{"id":21708,"date":"2024-05-27T11:00:45","date_gmt":"2024-05-27T10:00:45","guid":{"rendered":"https:\/\/www.ub.edu\/comitedebioseguretat\/uncategorized\/new-breakthrough-cancer-viral-immunotherapy\/"},"modified":"2024-05-27T11:23:25","modified_gmt":"2024-05-27T10:23:25","slug":"new-breakthrough-cancer-viral-immunotherapy","status":"publish","type":"post","link":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/resources\/new-breakthrough-cancer-viral-immunotherapy\/","title":{"rendered":"New breakthrough in cancer viral immunotherapy"},"content":{"rendered":"\n
\n
\n
\"Juan
The group led by Juan Jos\u00e9 Rojas, who is the principal investigator of the Immunology, Inflammation and Cancer group of the Faculty of Medicine and Health Sciences of the UB and IDIBELL, has carried out this research. In the picture, you can see, from left to right, Miquel Conesa, Maria Barcia, Juan Jos\u00e9 Rojas, Ana del Ca\u00f1izo and Carmen Bueno, key collaborators in this work.<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n

A research team formed by researchers from the University of Barcelona (UB), the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Munich has developed a new Vaccinia virus strain that represents a significant breakthrough in viral immunotherapy research and evidences its therapeutic potential to treat cancer patients. This new variant is able to replicate in tumor cells and, at the same time, maintains a high capacity to activate the patient’s immune defenses against tumors. The study, published in the scientific journal Molecular Therapy<\/a><\/em>, has received support from the Spanish Cancer Association and the State Research Agency. The virus has been shown to be effective in mouse models against various types of cancer such as melanoma, colon and kidney cancer. This advance represents a remarkable step forward in the research of viral immunotherapy and offers new hopes in the treatment of cancer.<\/p>\n<\/div>\n<\/div>\n\n

See the article on the UB’s website<\/a>.<\/p>\n\n

Reference article<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

A research team formed by researchers from the University of Barcelona (UB), the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Munich has developed a new Vaccinia virus strain that represents a significant breakthrough in viral immunotherapy research.<\/p>\n","protected":false},"author":1,"featured_media":21706,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[78],"tags":[91],"class_list":["post-21708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-resources","tag-sdg3"],"author_meta":{"display_name":"Comit\u00e8 de Bioseguretat","author_link":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/author\/ossmau1\/"},"featured_img":"https:\/\/www.ub.edu\/comitedebioseguretat\/wp-content\/uploads\/2024\/05\/tecnica-proves-laboratori-300x84.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["Resources<\/a>"],"unlinked":["Resources<\/span>"]},"tags":{"linked":["sdg3<\/a>"],"unlinked":["sdg3<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 2 years ago","modified":"Updated 2 years ago"},"absolute_dates":{"created":"Posted on 27 de May de 2024","modified":"Updated on 27 de May de 2024"},"absolute_dates_time":{"created":"Posted on 27 de May de 2024 11:00","modified":"Updated on 27 de May de 2024 11:23"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/posts\/21708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/comments?post=21708"}],"version-history":[{"count":2,"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/posts\/21708\/revisions"}],"predecessor-version":[{"id":21711,"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/posts\/21708\/revisions\/21711"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/media\/21706"}],"wp:attachment":[{"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/media?parent=21708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/categories?post=21708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ub.edu\/comitedebioseguretat\/en\/wp-json\/wp\/v2\/tags?post=21708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}